In patients with T2D, reduced GLP-1 levels were associated with enhanced oxidative stress markers and a higher risk for CV events,130 and GLP-1RA therapy ameliorated arterial stiffness, left ventricular myocardial deformation, and oxidative stress.131. This evidence concerns the gene GCG and type 2 diabetes mellitus.